MORhomes PLC
17 December 2024
NOT FOR
DISTRIBUTION TO ANY U.S. PERSON OR TO ANY PERSON OR ADDRESS IN THE
U.S.
MORhomes
PLC
Publication of
Pricing Supplement in relation to the issue of £12,500,000 3.40 per
cent. Secured Notes due 2038/2040 (to be consolidated and form a
single series with the existing £440,100,000 3.40 per cent. Notes
due 2038/2040 issued on 19 February 2019, 31 October 2019, 19
November 2019, 15 April 2020, 2 October, 26 October 2020, 26
January 2021, 26 March 2021, 8 November 2021 and 16 August 2022)
(the "Notes") under the £5,000,000,000 Secured Euro Medium Term
Note Programme (the "Programme")
MORhomes PLC (the "Issuer") has today published a pricing
supplement dated 17 December 2024 containing details of the Notes
(the "Pricing Supplement").
To view the Pricing Supplement, please paste the following URL into
the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/4566Q_1-2024-12-17.pdf
MORhomes PLC has also issued a press release,
which is available at the following URL:
http://www.rns-pdf.londonstockexchange.com/rns/4566Q_2-2024-12-17.pdf
For further information please
contact:
Andrew Morton
MORhomes PLC, Future Business Centre, Kings
Hedges Road, Cambridge CB4 2HY
07498 581246
DISCLAIMER ‑
INTENDED ADDRESSEES
Please note
that the information contained in the Pricing Supplement may be
addressed to and/or targeted at persons who are residents of
particular countries (specified or referred to in the Programme
Memorandum dated 11 January 2024 (the "Programme Memorandum") of
the Issuer in connection with the Programme only and is not
intended for use and should not be relied upon by any person
outside these countries and/or to whom the offer contained in the
Programme Memorandum is not addressed. Prior to relying on the
information contained in the Programme Memorandum and/or the
Pricing Supplement you must ascertain from the Programme Memorandum
whether or not you are part of the intended addressees of the
information contained therein.
Your right to
access the Pricing Supplement is conditional upon complying with
the above requirement.
